Gubra AS (STU:PI3) ROC (Joel Greenblatt) %: -309.90% (As of Dec. 2025)


STU:PI3 Gubra AS STU:PI3
58 GF Score
Price €46.00
GF Value €383.88
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS ROC (Joel Greenblatt) %?

Gubra AS STU:PI3 +7.33% 58 ROC (Joel Greenblatt) % is -309.90% as of Dec. 2025. GuruFocus rates STU:PI3 with a GF Score™ of 58/100 and a GF Value™ of €383.88 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,318 Biotechnology companies, Gubra AS ranks better than 99.01% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Gubra AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -309.90%.

The historical rank and industry rank for Gubra AS's ROC (Joel Greenblatt) % or its related term are showing as below:

STU:PI3' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -52.22   Med: 14.01   Max: 1853.92
Current: 1853.92

During the past 7 years, Gubra AS's highest ROC (Joel Greenblatt) % was 1853.92%. The lowest was -52.22%. And the median was 14.01%.

STU:PI3's ROC (Joel Greenblatt) % is ranked better than
99.01% of 1318 companies
in the Biotechnology industry
Industry Median: -294.23 vs STU:PI3: 1853.92

Gubra AS's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Gubra AS  (STU:PI3) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Gubra AS ROC (Joel Greenblatt) % Related Terms


Gubra AS ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Gubra AS's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS ROC (Joel Greenblatt) % Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 105.71 8.97 -52.16 -41.23 1,783.12

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -56.34 -45.80 -33.99 4,310.35 -309.90

STU:PI3 vs VRTX, REGN, ALNY: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, Gubra AS's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Gubra AS's ROC (Joel Greenblatt) % falls into.


STU:PI3
58GF Score
Gubra AS STU:PI3
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.05 + 0 + 0.892) - (203.345 + 0 + 11.414)
=-208.817

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.717 + 0 + 3.551) - (1.525 + 0 + 7.378)
=-0.63500000000001

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Gubra AS for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-49.71/( ( (14.409 + max(-208.817, 0)) + (17.672 + max(-0.63500000000001, 0)) )/ 2 )
=-49.71/( ( 14.409 + 17.672 )/ 2 )
=-49.71/16.0405
=-309.90 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -309.90% mean?
Gubra AS (STU:PI3) has a ROC (Joel Greenblatt) % of -309.90% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gubra AS and its competitors. According to the industry distribution chart, Gubra AS ranks #13 out of 1318 companies in the Biotechnology industry, placing it in the top 1%.
Is Gubra AS's ROC (Joel Greenblatt) % too high?
Gubra AS's current ROC (Joel Greenblatt) % is -309.90%. Based on the distribution chart, Gubra AS ranks #13 out of 1318 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gubra AS has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #13 out of 1318 companies for ROC (Joel Greenblatt) %. This places Gubra AS in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gubra AS and its competitors. Gubra AS's current ROC (Joel Greenblatt) % is -309.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (STU:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €383.88, compared to a current price of €46.00 — trading 88% below its estimated fair value. The current ROC (Joel Greenblatt) % is -309.90%. Gubra AS's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Gubra AS (STU:PI3), the current ROC (Joel Greenblatt) % is -309.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (STU:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €46.00 is trading 88% below its estimated GF Value™ of €383.88. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for STU:PI3:

  • ROC (Joel Greenblatt) %: -309.90%
  • GF Value™: €383.88 vs. price of €46.00 (88% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the STU:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gubra AS Business Description

Other Exchanges GUBRA:Denmark
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
58GF Score

Get the complete analysis for STU:PI3

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.00
Price
€383.88
GF Value